Open AccessAnalytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIV
Author(s) -
Emmanouil Papasavvas,
Steven M. Lada,
Jocelin Joseph,
Xiangfan Yin,
Qin Liu,
Livio Azzoni,
Karam Mounzer,
Jay R. Kostman,
Douglas D. Richman,
Luis J. Montaner
Publication year - 2018
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000001909
Subject(s) - viremia , peripheral blood mononuclear cell , cd38 , flow cytometry , viral load , antiretroviral therapy , reverse transcriptase , microbiology and biotechnology , digital polymerase chain reaction , immune system , biology , lentivirus , human immunodeficiency virus (hiv) , immunology , rna , virology , in vitro , viral disease , polymerase chain reaction , cd34 , gene , stem cell , biochemistry
The impact of short-term analytical treatment interruptions (ATI) on the levels of cellular HIV and of residual activation after subsequent antiretroviral therapy (ART)-mediated plasma HIV viral load re-suppression remains under active investigation.